ICICI Prudential Life Insurance Company Limited – Investor Presentation Summary

Key Operational Highlights

  • Retail Weighted Received Premium (RWRP) for May 2026: ₹4.94 billion with 6.2% Year-on-Year growth
  • Annualized Premium Equivalent (APE) for May 2026: ₹7.22 billion with 7.3% Year-on-Year growth
  • Retail APE for May 2026: ₹5.58 billion with (1.2%) Year-on-Year growth
  • New Business Premium for May 2026: ₹16.03 billion with 13.9% Year-on-Year growth
  • New Business Sum Assured for May 2026: ₹1,666.50 billion with 70.1% Year-on-Year growth
  • Two-month FY2027 cumulative RWRP: ₹9.15 billion with 13.9% Year-on-Year growth
  • Two-month FY2027 cumulative APE: ₹13.40 billion with 14.5% Year-on-Year growth
  • Two-month FY2027 cumulative Retail APE: ₹10.18 billion with 8.4% Year-on-Year growth
  • Two-month FY2027 cumulative New Business Premium: ₹28.99 billion with 18.8% Year-on-Year growth
  • Two-month FY2027 cumulative New Business Sum Assured: ₹3,443.33 billion with 27.2% Year-on-Year growth

Key drivers of operational performance: Not Specified

Segment-wise Performance

Performance by segment not specified in the data

Explanation of significant changes in segment performance: Not Specified

Financial Highlights

Revenue: Not Specified

EBITDA: Not Specified

PAT: Not Specified

EPS: Not Specified

Margins: Not Specified

YoY/QoQ comparison: Provided for premium metrics only

Drivers of financial performance: Not Specified

Comparison to market estimates: Not Specified

Key Risks: Not Specified

Geographical Revenue Split

Domestic vs Export/Regional Revenue: Not Specified

Regional Breakdown: Not Specified

Balance Sheet Snapshot

Net Debt/Equity: Not Specified

Reserves: Not Specified

Current Assets/Liabilities: Not Specified

Working Capital/Leverage Metrics: Not Specified

Financial Health Insights: Not Specified

Capex & Cash Flow Health

Capital Expenditure: Not Specified

Free Cash Flow: Not Specified

Operating Cash Flow: Not Specified

Net Debt Movement: Not Specified

Investment Rationale: Not Specified

Strategic & R&D Initiatives

Investments in Innovation: Not Specified

Expected impact on growth: Not Specified

Strategic Rationale: Not Specified

Industry Trends & Business Environment

Macro/Industry Trends: Not Specified

Impact on Company: Not Specified

Management Commentary & Growth Outlook

Strategic Outlook: Not Specified

FY Guidance: Not Specified

Market Share Targets: Not Specified

Risks and Opportunities: Not Specified